Please use this identifier to cite or link to this item: http://hdl.handle.net/2381/1221
Full metadata record
DC FieldValueLanguage
dc.contributor.authorThomas, Anne L.en_GB
dc.contributor.authorMorgan, B.en_GB
dc.contributor.authorDrevs, J.en_GB
dc.contributor.authorUnger, C.en_GB
dc.contributor.authorWiedenmann, Bertramen_GB
dc.contributor.authorVanhoefer, Udoen_GB
dc.contributor.authorLaurent, Dirken_GB
dc.contributor.authorDugan, M.en_GB
dc.contributor.authorSteward, William P.en_GB
dc.date.accessioned2007-10-24T10:12:22Z-
dc.date.available2007-10-24T10:12:22Z-
dc.date.issued2003en_GB
dc.identifier.citationSeminars in Oncology, 2003, 30 (3 Suppl 6), pp.32-38en_GB
dc.identifier.issn0093-7754en_GB
dc.identifier.urihttp://www2.us.elsevierhealth.com/inst/serve?article=as0093775403001234&arttype=absen_GB
dc.identifier.urihttp://hdl.handle.net/2381/1221-
dc.descriptionMetadata only entry-
dc.formatMetadata-
dc.language.isoenen_GB
dc.titleVascular endothelial growth factor receptor tyrosine kinase inhibitors: PTK787/ZK 222584en_GB
dc.typeArticleen_GB
dc.relation.raeRAE 2007-
Appears in Collections:Published Articles, Dept. of Cancer Studies and Molecular Medicine

Files in This Item:
There are no files associated with this item.


Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.